Sio Capital Management’s Precision BioSciences DTIL Stock Holding History

Sio Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,633	Closed	-$1.61M	–	55
2022 Q2	$1.61M	Buy	+33,633	New	+$1.97M	0.61%	35
2022 Q1	–	Sell	-8,572	Closed	-$1.9M	–	71
2021 Q4	$1.9M	Hold	8,572	–	–	0.57%	43
2021 Q3	$2.97M	Sell	8,572 -1,209	-12%	-$410K	0.95%	35
2021 Q2	$3.67M	Sell	9,781 -1,198	-11%	-$360K	0.91%	40
2021 Q1	$3.41M	Buy	10,979 +391	+4%	+$137K	0.69%	47
2020 Q4	$2.65M	Sell	10,588 -1,277	-11%	-$313K	0.54%	59
2020 Q3	$2.19M	Buy	11,865 +5,697	+92%	+$1.13M	0.43%	57
2020 Q2	$1.54M	Buy	+6,168	New	+$1.35M	0.45%	55
2020 Q1	–	Sell	-1,448	Closed	-$603K	–	74
2019 Q4	$603K	Buy	+1,448	New	+$455K	0.14%	64

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Sio Capital Management's DTIL Position: Q3 2022 in Review

Sio Capital Management sold out of Precision BioSciences (DTIL) in Q3 2022, closing a stake of 33,633 shares — an estimated $1.61M sold.

Sio Capital Management first reported a position in DTIL in Q4 2019 and held it in 9 quarters. The position peaked at $3.67M in Q2 2021. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

Sio Capital Management reported no remaining Precision BioSciences position as of Q3 2022 after selling out during the quarter.
Sio Capital Management sold 33,633 Precision BioSciences shares in Q3 2022, an estimated $1.61M.
Sio Capital Management first reported a position in Precision BioSciences in Q4 2019 and held it in 9 quarters.
Sio Capital Management's Precision BioSciences position peaked at $3.67M in Q2 2021.
102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.